Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia
Sponsor: Enliven Therapeutics
Summary
The purpose of this study is to evaluate the safety, tolerability and determine the recommended dose for further clinical evaluation of ELVN-001 in patients with chronic myeloid leukemia with and without T315I mutations in patients who are relapsed, refractory or intolerant to TKIs.
Official title: A Phase 1a/1b Study of ELVN-001 for the Treatment of Chronic Myeloid Leukemia
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
250
Start Date
2022-05-22
Completion Date
2027-12
Last Updated
2026-04-01
Healthy Volunteers
No
Interventions
ELVN-001
orally once or twice daily
Locations (45)
Memorial Sloan Kettering Cancer Center
New York, New York, United States
Montefiore Medical Center
The Bronx, New York, United States
Oregon Health & Science University-Knight Cardiovascular Institute
Portland, Oregon, United States
The University of Texas MD Anderson Cancer Center
Houston, Texas, United States
Royal Adelaide Hospital
Adelaide, Australia
UZ Gent
Ghent, Belgium
UZ Leuven
Leuven, Belgium
CHU Liege
Liège, Belgium
University Health Network (UHN) - Princess Margaret Cancer Centre
Toronto, Ontario, Canada
CHU Amiens Picardie Site Sud
Amiens, France
Institut Bergonie - Centre Regional de Lutte Contre Le Cancer de Bordeaux et Sud Ouest
Bordeaux, France
CHRU de Lille - Hopital Calmette-Boulevard du Pr Leclercq CHRU Lille
Lille, France
Centre Hospitalier Universitaire (CHU) De Limoges Hopital Dupuytren
Limoges, France
Centre Leon Berard
Lyon, France
Centre Hospitalier Lyon Sud
Pierre-Bénite, France
Uniklinik RWTH Aachen Medizinische
Aachen, Germany
Charite Campus Virchow
Berlin, Germany
Klinikum der Goethe Universitat
Frankfurt, Germany
Universitaetsklinikum Des Saarlandes Und Medizinische Fakultaet Der Universitaet Des Saarlandes
Homburg, Germany
Universitaetsklinikum Jena
Jena, Germany
Medizinische Universitatsklinik Mannheim der Universitat Heidelberg
Mannheim, Germany
Universitaetsmedizin Rostock
Rostock, Germany
Semmelweis Egyetem, Belgyogyaszati es Onkologiai Klinika
Budapest, Hungary
Pecsi Tudomanyegyetem Klinikai Kozpont (University of Pecs, Clinical Centre)
Pécs, Hungary
Hadassah Medical Center
Jerusalem, Israel
The Galilee Medical Center
Nahariya, Israel
Rabin Medical Center
Petah Tikva, Israel
Azienda Ospedaliero Universitaria Delle Marche
Ancona, Italy
Radboud University Medical Center
Nijmegen, Netherlands
Szpital Specjalistycnzy im. Jedrzeja Sniadeckiego w Nowym Saczu
Nowy Sącz, Poland
MICS Centrum Medyczne Torun
Torun, Poland
Instytut Hematologii I Transfuzjologii
Warsaw, Poland
Chonbuk National University Hospital
Jeonju, Jeollabuk-do, South Korea
Keimyung University Dongsan Hospital
Daegu, South Korea
Uijeongbu Eulji Medical Center
Gyeonggi-do, South Korea
Chonnam National University Hwasun Hospital
Hwasun, South Korea
Samsung Medical Center
Seoul, South Korea
Hospital Del Mar
Barcelona, Spain
Hospital Universitario de Gran Canaria Dr. Negrin, Servicio Canario e Salud (SCS)
Las Palmas de Gran Canaria, Spain
Hospital Universitario La Paz
Madrid, Spain
Complejo Hospitalario de Toledo - Hospital Virgen de la Salud
Toledo, Spain
Universitat de Valencia - Hospital Universitari i Politecnic La Fe de Valencia (Hospital La Fe Bulevar Sur)
Valencia, Spain
Beatson West of Scotland Cancer Centre, Gartnavel General Hospital
Glasgow, United Kingdom
Hammersmith Hospital Imperial College Healthcare NHS Trust
London, United Kingdom
The Christie NHS Foundation Trust
Manchester, United Kingdom